Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Clinical trial NCT03260504 · TERMINATED

Trial details

NCT number: NCT03260504
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Metastatic Clear Cell Renal Cell Carcinoma

Start date: 2018-08-28
Primary completion: 2022-07-26
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.